New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
11:38 EDTAWAY, DDS, PSTI, EBIX, GGBHigh option volume stocks: GGB PSTI AWAY EBIX DDS
News For GGB;PSTI;AWAY;EBIX;DDS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 1, 2015
10:00 EDTDDSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:26 EDTDDSDillard's initiated with a Hold at Deutsche Bank
Target $116.
June 30, 2015
11:07 EDTAWAYPriceline rises after analysts highlight positive travel trends
Subscribe for More Information
07:41 EDTAWAYOnline travel trends point to solid Q2, says Piper Jaffray
Piper Jaffray analyst Michael Olson said analysis of travel industry trends through May point to a "solid" second quarter for online travel, noting his belief that Priceline (PCLN) has the most favorable risk/reward in the space given the stock's underperformance so far this year. In addition to an Overweight rating on Priceline, Olson keeps an Overweight on HomeAway (AWAY) and TripAdvisor (TRIP), but has a Neutral rating on Expedia (EXPE), citing its relative valuation.
June 25, 2015
09:52 EDTPSTIPluristem raises $17M in a registered direct offering
Subscribe for More Information
June 24, 2015
05:30 EDTPSTIPluristem granted Australian patent for 3D cell expansion technology
Pluristem Therapeutics announced that it has been granted an Australian patent titled "Adherent Cells From Placenta Tissue and Use Thereof in Therapy". Patent #2009288781 covers Pluristem's proprietary, three-dimensional method of growing cells from placental or adipose tissue, cells produced by the process, and the use of such cells in the potential treatment of a broad range of conditions. These include peripheral artery disease, other ischemic and cardiovascular diseases, graft-versus-host disease, organ transplantation, cancer, and autoimmune diseases. The patent term will extend until 2027.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use